Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 6, 2014Antiviral ResearchOpen Access

High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses

View Full Paper
Ask AI
Bookmark
Share

Authors

LULuke S. UebelhoerOregon National Primate Research CenterCACésar G. AlbariñoCenters for Disease Control and PreventionLMLaura K. McMullanCenters for Disease Control and Prevention

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Uebelhoer et al. (2014) studied this question.

synapsesocial.com/papers/6a611a0d93038f56f37c588dhttps://doi.org/10.1016/j.antiviral.2014.03.018
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Novel pyrazolo[3,4-d]pyrimidine nucleoside analog with broad-spectrum antiviral activity1987 · 50 citations
  2. 2Three of the Four Nucleocapsid Proteins of Marburg Virus, NP, VP35, and L, Are Sufficient To Mediate Replication and Transcription of Marburg Virus-Specific Monocistronic Minigenomes1998 · 230 citations
  3. 3Basic Residues within the Ebolavirus VP35 Protein Are Required for Its Viral Polymerase Cofactor Function2010 · 89 citations
  4. 4In Vitro and In Vivo Characterization of Recombinant Ebola Viruses Expressing Enhanced Green Fluorescent Protein2007 · 77 citations